UBS Group AG - EVAXION BIOTECH A S ownership

EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 14 filers reported holding EVAXION BIOTECH A S in Q1 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of EVAXION BIOTECH A S
ValueSharesWeighting
Q3 2023$3,336
+1046.4%
4,005
+1704.1%
0.00%
Q2 2023$291
-96.1%
222
-96.6%
0.00%
Q1 2023$7,435
-17.8%
6,580
+29.5%
0.00%
Q4 2022$9,044
+29.2%
5,081
+92.0%
0.00%
Q3 2022$7,000
+250.0%
2,647
+140.2%
0.00%
Q2 2022$2,000
-66.7%
1,102
-43.6%
0.00%
Q1 2022$6,000
-62.5%
1,955
-44.5%
0.00%
Q4 2021$16,000
-27.3%
3,522
+55.8%
0.00%
Q3 2021$22,000
+57.1%
2,261
+27.9%
0.00%
Q2 2021$14,0001,7680.00%
Other shareholders
EVAXION BIOTECH A S shareholders Q1 2022
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 18,071$32,5280.14%
Telemetry Investments, L.L.C. 37,500$680.11%
Beacon Capital Management, LLC 6,881$12,2140.00%
PURA VIDA INVESTMENTS, LLC 16,842$29,8950.00%
MORGAN STANLEY 3,696$6,5600.00%
Citadel Advisors 13,000$23,4000.00%
Citadel Advisors 500$9000.00%
Citadel Advisors 1,485$2,6730.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 41,600$74,8800.00%
UBS Group AG 5,081$9,0440.00%
View complete list of EVAXION BIOTECH A S shareholders